Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ and Den Dunnen JT. 2006. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 34:135–144.
Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S, Tomaru K, Sekiguchi K, Arai M, Nakamura T and Nagai R. 2000. Cardiac ankyrin repeat protein is a novel marker of car- diac hypertrophy: role of M-CAT element within the promoter. Hypertension 36:48–53.
Anderson KM, Berrebi-Bertrand I, Kirkpatrick RB, McQueney MS, Underwood DC, Rouanet S and Chabot-Fletcher M. 1999. cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy. J Mol Cell Cardiol 31:705–719.
Ayalon G, Davis JQ, Scotland PB and Bennett V. 2008. An ankyrin- based mechanism for functional organization of dystrophin and dystroglycan. Cell 135:1189–1200.
Bakay M, Zhao P, Chen J and Hoffman EP. 2002. A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord 12 Suppl 1:S125–141.
Bang ML, Mudry RE, McElhinny AS, Trombitas K, Geach AJ, Yamasaki R, Sorimachi H, Granzier H, Gregorio CC and Labeit S. 2001. Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. J Cell Biol 153:413–427.
Barash IA, Mathew L, Ryan AF, Chen J and Lieber RL. 2004. Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse. Am J Physiol Cell Physiol 286:C355–364.
Barash IA, Bang ML, Mathew L, Greaser ML, Chen J and Lieber RL. 2007. Structural and regulatory roles of muscle ankyrin repeat protein family in skeletal muscle. Am J Physiol Cell Physiol 293:C218–227.
Baumeister A, Arber S and Caroni P. 1997. Accumulation of muscle ankyrin repeat protein transcript reveals local activation of pri- mary myotube endcompartments during muscle morphogenesis. J Cell Biol 139:1231–1242.
Bello NF, Lamsoul I, Heuze ML, Metais A, Moreaux G, Calderwood DA, Duprez D, Moog-Lutz C and Lutz PG. 2009. The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation. Cell Death Differ 16:921–932.
Bennett V. 1978. Purification of an active proteolytic fragment of the membrane attachment site for human erythrocyte spectrin. J Biol Chem 253:2292–2299.
Bennett V and Baines AJ. 2001. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev 81:1353–1392.
Boengler K, Pipp F, Fernandez B, Richter A, Schaper W and Deindl E. 2003. The ankyrin repeat containing SOCS box protein 5: a novel protein associated with arteriogenesis. Biochem Biophys Res Commun 302:17–22.
Borzok MA, Catino DH, Nicholson JD, Kontrogianni-Konstantopoulos A and Bloch RJ. 2007. Mapping the binding site on small ankyrin 1 for obscurin. J Biol Chem 282:32384–32396.
Brand-Saberi B and Christ B. 2000. Evolution and development of distinct cell lineages derived from somites. Curr Top Dev Biol 48:1–42.
Breeden L and Nasmyth K. 1987. Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila. Nature 329:651–654.
Bryson-Richardson RJ and Currie PD. 2008. The genetics of vertebrate myogenesis. Nat Rev Genet 9:632–646.
Cardamone M, Darras BT and Ryan MM. 2008. Inherited myopathies and muscular dystrophies. Semin Neurol 28:250–259.
Casey WM, Brodie T, Yoon L, Ni H, Jordan HL and Cariello NF. 2008. Correlation analysis of gene expression and clinical chemistry to identify biomarkers of skeletal myopathy in mice treated with PPAR agonist GW610742X. Biomarkers 13:364–376.
Charge SB and Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209–238.
Chen L, Ong B and Bennett V. 2001. LAD-1, the Caenorhabditis elegans L1CAM homologue, participates in embryonic and gonadal mor- phogenesis and is a substrate for fibroblast growth factor receptor pathway-dependent phosphotyrosine-based signaling. J Cell Biol 154:841–855.
Chu W, Burns DK, Swerlick RA and Presky DH. 1995. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J Biol Chem 270:10236–10245.
Chung AS, Guan YJ, Yuan ZL, Albina JE and Chin YE. 2005. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II. Mol Cell Biol 25:4716–4726.
Diks SH, Sartori Da Silva MA, Hillebrands JL, Bink RJ, Versteeg HH, Van Rooijen C, Brouwers A, Chitnis AB, Peppelenbosch MP and Zivkovic D. 2008. d-Asb11 is an essential mediator of canonical Delta-Notch signalling. Nat Cell Biol 10:1190–1198.
Fortini ME. 2001. Notch and presenilin: a proteolytic mechanism emerges. Curr Opin Cell Biol 13:627–634.